4/24
08:07 am
cara
Oruka Therapeutics Expands Leadership Team, Naming Joana Goncalves, MBChB, as Chief Medical Officer [Yahoo! Finance]
Medium
Report
Oruka Therapeutics Expands Leadership Team, Naming Joana Goncalves, MBChB, as Chief Medical Officer [Yahoo! Finance]
4/22
05:11 am
cara
Uremic Pruritus Pipeline Insight 2024, Featuring Key Players Cara Therapuetics and Lumosa Therapeutics, and Key Emerging Drugs Cara Therapeutics CR845 and Lumos Therapeutics' LT 5001 [Yahoo! Finance]
High
Report
Uremic Pruritus Pipeline Insight 2024, Featuring Key Players Cara Therapuetics and Lumosa Therapeutics, and Key Emerging Drugs Cara Therapeutics CR845 and Lumos Therapeutics' LT 5001 [Yahoo! Finance]
4/10
08:05 am
cara
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Medium
Report
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
4/2
07:00 am
cara
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Low
Report
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
3/28
08:07 am
cara
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Low
Report
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
3/7
07:03 am
cara
Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024 [Yahoo! Finance]
Medium
Report
Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024 [Yahoo! Finance]
3/7
07:00 am
cara
Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
Medium
Report
Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
3/7
06:11 am
cara
Analysts Have Made A Financial Statement On Cara Therapeutics, Inc.'s (NASDAQ:CARA) Yearly Report [Yahoo! Finance]
Medium
Report
Analysts Have Made A Financial Statement On Cara Therapeutics, Inc.'s (NASDAQ:CARA) Yearly Report [Yahoo! Finance]
3/6
11:04 pm
cara
Cara Therapeutics, Inc. (NASDAQ: CARA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Cara Therapeutics, Inc. (NASDAQ: CARA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/6
08:10 am
cara
Cara Therapeutics, Inc. (NASDAQ: CARA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $11.00 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
Cara Therapeutics, Inc. (NASDAQ: CARA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $11.00 to $10.00. They now have a "buy" rating on the stock.
3/6
05:49 am
cara
Cara Therapeutics Full Year 2023 Earnings: Misses Expectations [Yahoo! Finance]
High
Report
Cara Therapeutics Full Year 2023 Earnings: Misses Expectations [Yahoo! Finance]
3/5
08:15 am
cara
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Medium
Report
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
3/4
04:22 pm
cara
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Low
Report
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
3/4
04:01 pm
cara
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
Medium
Report
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
2/24
02:04 am
cara
Cara Therapeutics, Inc. (NASDAQ: CARA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
High
Report
Cara Therapeutics, Inc. (NASDAQ: CARA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
2/21
10:30 am
cara
We're A Little Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Rate [Yahoo! Finance]
Medium
Report
We're A Little Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Rate [Yahoo! Finance]
2/16
10:03 pm
cara
Cara Therapeutics, Inc. (NASDAQ: CARA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Cara Therapeutics, Inc. (NASDAQ: CARA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/12
04:15 pm
cara
Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024 [Yahoo! Finance]
Medium
Report
Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024 [Yahoo! Finance]
2/12
04:01 pm
cara
Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
Medium
Report
Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024